Dr Reddys Laboratories Share Price Today - Live Blog for April 17, 2025

Dr Reddys Laboratories Ltd's shares experienced a 0.07% uptick, and they are currently valued at ₹1,163.80, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.12%, signalling a challenging period. Currently trading at ₹1,163.25, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,164.55, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price has declined by -0.06%, and it's currently trading at ₹1,165.70. The stock maintains a PE of 18.0100, while the industry PE is 33.6111, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's share price rallied by 0.26%, reaching the current market price of ₹1,165.90. This surge is indicative of the stock's recent positive performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.34% in its share price, and it currently trades at ₹1,163.00 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd shares saw a -0.21% decrease, reaching a current market price of ₹1,166.15. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a -0.10% decrease in its share price, and it is currently trading at ₹1,167.55. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

With a remarkable 0.18% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,168.60. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.0100, while the industry's PE ratio is 33.6111.

Dr Reddys Laboratories Ltd shares experienced a -0.03% reduction, with the current market price at ₹1,166.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.14% decline, and it currently trades at ₹1,167.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,168.95. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd shares saw a -0.21% decrease, reaching a current market price of ₹1,167.55. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd experienced a -0.21% dip in its share price and is currently trading at ₹1,167.55. The stock has a PE ratio of 18.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.15% drop, and it's now trading at ₹1,168.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.10%. At this moment, it's actively trading at ₹1,170.20, presenting an enticing opportunity for those in the market.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.08% increase and currently trading at ₹1,171.00 per share. Investors are taking notice of this upward momentum.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.08%. At this moment, it's actively trading at ₹1,168.95, presenting an enticing opportunity for those in the market.

Following a noteworthy 0.18% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,167.65. When it comes to valuation, this stock has a PE ratio of 18.0100, with the industry PE ratio at 33.6111.

Dr Reddys Laboratories Ltd observed a remarkable 0.03% surge in its share price and is presently trading at ₹1,165.60. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's shares experienced a 0.39% uptick, and they are currently valued at ₹1,165.25, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.45% boost, with the current market value at ₹1,161.60 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.13%, reaching the current market price of ₹1,155.80. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd experienced a -0.03% slump and is currently trading at ₹1,157.00. While the stock maintains a PE ratio of 18.0100, the industry PE is 33.6111, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.55%, signalling a challenging period. Currently trading at ₹1,156.55, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's stock has surged by 0.07%, and it is currently trading at ₹1,162.50. Additionally, the stock maintains a PE ratio of 18.0100, while the industry PE is 33.6111.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.07% uptick in its share price. As a result, it's now actively trading at ₹1,160.35 per share, making it an attractive option for investors.